Drug approval

Drug approval is a process that involves the regulatory authorities' authorization for the marketing of a drug or medication after a thorough examination of its safety, efficacy, and quality. This process is crucial in ensuring that the drugs available to the public are safe and effective.

Overview

The drug approval process begins with the discovery and development of a new drug. This involves extensive laboratory testing and preclinical trials. Once the drug has shown promise in these initial stages, it moves on to clinical trials, which are conducted in several phases. The data from these trials is then submitted to the regulatory authorities for review.

Drug Discovery and Development

The process of drug discovery involves the identification of potential new drugs from natural sources, genetic engineering, or artificial synthesis in a laboratory. Once a potential drug has been identified, it undergoes development, which involves laboratory and animal testing to determine its safety and efficacy.

Clinical Trials

Clinical trials are conducted in several phases. Phase I trials involve a small group of healthy volunteers and aim to determine the drug's safety, dosage, and side effects. Phase II trials involve a larger group of patients and aim to assess the drug's efficacy and side effects. Phase III trials involve a large group of patients and aim to confirm the drug's efficacy, monitor its side effects, compare it to commonly used treatments, and collect information that will allow the drug to be used safely.

Regulatory Review and Approval

Once the clinical trials are complete, the data is submitted to the regulatory authorities for review. This review process involves a thorough examination of the drug's safety, efficacy, and quality. If the regulatory authorities are satisfied with the data, they will approve the drug for marketing.

Post-Marketing Surveillance

After a drug has been approved and is on the market, it undergoes post-marketing surveillance. This involves monitoring the drug's performance in the general population and reporting any adverse reactions or side effects that were not identified in the clinical trials.

See Also

• Clinical trial
• Regulatory authorities
• Drug discovery
• Drug development

References

Drug approval Resources
Latest articles Most recent articles Ongoing trials	Wikipedia